Health Dictionary Find a Doctor

Non small cell lung cancer pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Trusha Tank, M.D.[2],Maria Fernanda Villarreal, M.D. [3]

Overview

Overview

Non-small cell lung cancer arises from the epithelial cells of the bronchioles and alveoli, which are normally involved in the protection of the airways. Non-small cell lung cancer is an invasive and rapidly growing cancer which may metastasize to different organs of the body. Genes involved in the pathogenesis of non-small cell lung cancer include EGFR, KRAS, HER2, BRAF, and ALK. Findings on gross pathology depends on the histological subtypes of non-small cell lung cancer. On microscopic histopathological analysis non-small cell lung cancer usually demonstrates large cells with abundant cytoplasm and no stippled chromatin.

Pathogenesis

Pathogenesis

The pathogenesis of non-small cell lung cancer depends on the type of histological subtype of lung cancer.[1]

Pathogenesis according to histopathological subtypes:

Genetics

Genetics

Development of non-small cell lung cancer is the result of multiple genetic mutations. Genetic mutations also play an important role in the treatment selection for non small cell lung cancer.[4]

  • The table below describes the genes involved in the pathogenesis of non small cell lung cancer.
Genes Presence in non small cell-lung cancers
EGFR
  • EGFR mutations are present in approximately 10% to 15% of all non-small cell lung cancers
KRAS
  • Mutations are present in approximately 30% of pulmonary adenocarcinomas
  • Mutations are present in approximately 5% of pulmonary squamous cell carcinomas
  • Associated with carcinomas with mucinous histology
ALK
  • Mutations are present in approximately 5% of all non-small cell lung cancers
HER2
  • Mutations are present in approximately 4% of adenocarcinomas
BRAF
  • Mutations are present in less than 2% of adenocarcinomas
ROS-1
  • Mutations are present in less than 2% of adenocarcinomas
Associated Conditions

Associated Conditions

Other conditions associated with non-small cell lung cancer, include:

Gross Pathology

Gross Pathology

On gross pathology, findings will depend on the histological subtype of non-small cell lung cancer.

Microscopic Pathology

Microscopic Pathology

On microscopic pathology, findings will depend on the histological type of non-small cell lung cancer.

  • Squamous cell carcinoma of the lung:[13]
    • Central nucleus
    • Dense appearing cytoplasm, usually eosinophilic
    • Small nucleolus
    • Intercellular bridges (classic feature)
    • For more information on microscopic pathological findings of squamous cell carcinoma of the lung, click here.


References

References

  1. Miller YE (2005). “Pathogenesis of lung cancer: 100 year report”. Am. J. Respir. Cell Mol. Biol. 33 (3): 216–23. doi:10.1165/rcmb.2005-0158OE. PMC 2715312. PMID 16107574.
  2. 2.0 2.1 Thunnissen E (December 2012). “Pulmonary adenocarcinoma histology”. Transl Lung Cancer Res. 1 (4): 276–9. doi:10.3978/j.issn.2218-6751.2012.10.11. PMC 4367552. PMID 25806193.
  3. Suarez E, Knollmann-Ritschel B (2017). “Squamous Cell Carcinoma of the Lung”. Acad Pathol. 4: 2374289517705950. doi:10.1177/2374289517705950. PMC 5528918. PMID 28815199. Vancouver style error: initials (help)
  4. Capelozzi VL (2009). “Role of immunohistochemistry in the diagnosis of lung cancer”. J Bras Pneumol. 35 (4): 375–82. PMID 19466276.
  5. Caron, Olivier; Frebourg, Thierry; Benusiglio, Patrick R.; Foulon, Stéphanie; Brugières, Laurence (2017). “Lung Adenocarcinoma as Part of the Li-Fraumeni Syndrome Spectrum”. JAMA Oncology. 3 (12): 1736. doi:10.1001/jamaoncol.2017.1358. ISSN 2374-2437.
  6. Sekido Y, Bader S, Latif F, Gnarra JR, Gazdar AF, Linehan WM, Zbar B, Lerman MI, Minna JD (June 1994). “Molecular analysis of the von Hippel-Lindau disease tumor suppressor gene in human lung cancer cell lines”. Oncogene. 9 (6): 1599–604. PMID 8183553.
  7. Liang H, Pan Z, Cai X, Wang W, Guo C, He J, Chen Y, Liu Z, Wang B, He J, Liang W (June 2018). “The association between human papillomavirus presence and epidermal growth factor receptor mutations in Asian patients with non-small cell lung cancer”. Transl Lung Cancer Res. 7 (3): 397–403. doi:10.21037/tlcr.2018.03.16. PMC 6037964. PMID 30050777.
  8. Skowroński M, Iwanik K, Halicka A, Barinow-Wojewódzki A (2015). “Squamous cell lung cancer in a male with pulmonary tuberculosis”. Pneumonol Alergol Pol. 83 (4): 298–302. doi:10.5603/PiAP.2015.0049. PMID 26166791.
  9. Suarez E, Knollmann-Ritschel B (2017). “Squamous Cell Carcinoma of the Lung”. Acad Pathol. 4: 2374289517705950. doi:10.1177/2374289517705950. PMC 5528918. PMID 28815199. Vancouver style error: initials (help)
  10. 10.0 10.1 Miller YE (2005). “Pathogenesis of lung cancer: 100 year report”. Am. J. Respir. Cell Mol. Biol. 33 (3): 216–23. doi:10.1165/rcmb.2005-0158OE. PMC 2715312. PMID 16107574.
  11. Suarez E, Knollmann-Ritschel B (2017). “Squamous Cell Carcinoma of the Lung”. Acad Pathol. 4: 2374289517705950. doi:10.1177/2374289517705950. PMC 5528918. PMID 28815199. Vancouver style error: initials (help)
  12. Suarez E, Knollmann-Ritschel B (2017). “Squamous Cell Carcinoma of the Lung”. Acad Pathol. 4: 2374289517705950. doi:10.1177/2374289517705950. PMC 5528918. PMID 28815199. Vancouver style error: initials (help)
  13. Suarez E, Knollmann-Ritschel B (2017). “Squamous Cell Carcinoma of the Lung”. Acad Pathol. 4: 2374289517705950. doi:10.1177/2374289517705950. PMC 5528918. PMID 28815199. Vancouver style error: initials (help)


Template:WikiDoc Sources

Looking for the patient version?

Back to the patient-friendly article

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH